This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2009 May:20 Suppl 4:129-31.

doi: 10.1093/annonc/mdp152.

Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

R Dummer¹, A Hauschild, G Pentheroudakis

Affiliations

PMID: 19454433
DOI: 10.1093/annonc/mdp152

Review

Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

R Dummer et al. Ann Oncol. 2009 May.

. 2009 May:20 Suppl 4:129-31.

doi: 10.1093/annonc/mdp152.

Authors

R Dummer¹, A Hauschild, G Pentheroudakis

Affiliation

¹ Department of Dermatology, University of Kiel, Kiel, Germany.

PMID: 19454433
DOI: 10.1093/annonc/mdp152

No abstract available

PubMed Disclaimer

Similar articles

Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Willemze R, Dreyling M; ESMO Guidelines Working Group. Willemze R, et al. Ann Oncol. 2009 May;20 Suppl 4:115-8. doi: 10.1093/annonc/mdp147. Ann Oncol. 2009. PMID: 19454428 Review. No abstract available.
Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Stupp R, Roila F; ESMO Guidelines Working Group. Stupp R, et al. Ann Oncol. 2009 May;20 Suppl 4:126-8. doi: 10.1093/annonc/mdp151. Ann Oncol. 2009. PMID: 19454432 Review. No abstract available.
Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Stahel RA, Weder W, Felip E; ESMO Guidelines Working Group. Stahel RA, et al. Ann Oncol. 2009 May;20 Suppl 4:73-5. doi: 10.1093/annonc/mdp134. Ann Oncol. 2009. PMID: 19454470 Review. No abstract available.
Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Dummer R, Hauschild A, Jost L; ESMO Guidelines Working Group. Dummer R, et al. Ann Oncol. 2008 May;19 Suppl 2:ii86-8. doi: 10.1093/annonc/mdn100. Ann Oncol. 2008. PMID: 18456782 No abstract available.
Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Chan AT, Felip E; ESMO Guidelines Working Group. Chan AT, et al. Ann Oncol. 2009 May;20 Suppl 4:123-5. doi: 10.1093/annonc/mdp150. Ann Oncol. 2009. PMID: 19454431 Review. No abstract available.

See all similar articles

Cited by

Prognostic value of [18F]-fluoro-deoxy-glucose PET/CT, S100 or MIA for assessment of cancer-associated mortality in patients with high risk melanoma.
Essler M, Link A, Belloni B, Mirceva V, Souvatzoglou M, Thaler M, Haller B, Hein R, Krause BJ. Essler M, et al. PLoS One. 2011;6(9):e24632. doi: 10.1371/journal.pone.0024632. Epub 2011 Sep 14. PLoS One. 2011. PMID: 21935432 Free PMC article.
Repressing CD147 is a novel therapeutic strategy for malignant melanoma.
Hu X, Su J, Zhou Y, Xie X, Peng C, Yuan Z, Chen X. Hu X, et al. Oncotarget. 2017 Apr 11;8(15):25806-25813. doi: 10.18632/oncotarget.15709. Oncotarget. 2017. PMID: 28445958 Free PMC article. Review.
Long-term follow-up for melanoma patients: is there any evidence of a benefit?
Rueth NM, Cromwell KD, Cormier JN. Rueth NM, et al. Surg Oncol Clin N Am. 2015 Apr;24(2):359-77. doi: 10.1016/j.soc.2014.12.012. Epub 2015 Jan 24. Surg Oncol Clin N Am. 2015. PMID: 25769718 Free PMC article. Review.
F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review.
Schröer-Günther MA, Wolff RF, Westwood ME, Scheibler FJ, Schürmann C, Baumert BG, Sauerland S, Kleijnen J. Schröer-Günther MA, et al. Syst Rev. 2012 Dec 13;1:62. doi: 10.1186/2046-4053-1-62. Syst Rev. 2012. PMID: 23237499 Free PMC article.
The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells.
Le MN, Chan JL, Rosenberg SA, Nabatian AS, Merrigan KT, Cohen-Solal KA, Goydos JS. Le MN, et al. J Invest Dermatol. 2010 Sep;130(9):2240-9. doi: 10.1038/jid.2010.126. Epub 2010 May 27. J Invest Dermatol. 2010. PMID: 20505744 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information